Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults

NCT01215149 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

218

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: Ad35-ENV vaccine
BIOLOGICAL: Ad26.ENVA.01 vaccine
BIOLOGICAL: Placebo Control

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]